Swedish Orphan Biovitrum AB (1SOBI)
MTA
Real-time Data
07:00 AM
Day's Range
41.7052 wk Range
25.72Overview - 1SOBI - Swedish Orphan Biovitrum AB
Key Statistics
Valuation
Enterprise Value
20.69B
P/E (Trailing)
‪118.85‬
PEG Ratio
‪4.88‬
Price / Sales (TTM)
‪0.36‬
Price / Book
‪0.39‬
EV / EBITDA
‪1.89‬
Profitability
Gross Margin
‪76.67%‬
Profit Margin
‪4.51%‬
Operating Margin
‪2.96%‬
Return on Assets
‪7.70%‬
Return on Equity
‪3.40%‬
Ownership
Shares Outstanding
347.28M
Float
223.20M
Held by Insiders
‪10.05%‬
Held by Institutions
‪75.15%‬
Price stats
Beta
‪0.27‬
50-Day Avg
‪38.84‬
200-Day Avg
‪35.12‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1SOBI - Swedish Orphan Biovitrum AB
Peers - 1SOBI - Swedish Orphan Biovitrum AB
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on MTA.
- 1SOBIMTASwedish Orphan Biovitrum AB10.24BMarket Cap+38.32%52-week change118.86P/E (Trailing)‪4.51%‬Profit Margin
- 1MRKMTAMerck KGaA55.65BMarket Cap+20.17%52-week change23.47P/E (Trailing)‪11.21%‬Profit Margin
- 1ZTSMTAZoetis Inc.48.46BMarket Cap-106.01%52-week change12.02P/E (Trailing)‪27.68%‬Profit Margin
- 1GALDMTAGalderma Group AG41.32BMarket Cap+22.58%52-week change56.73P/E (Trailing)‪14.57%‬Profit Margin
- 1NBIXMTANeurocrine Biosciences Inc.12.55BMarket Cap+21.07%52-week change22.56P/E (Trailing)‪20.91%‬Profit Margin
- 1VTRSMTAViatris Inc.12.51BMarket Cap+36.15%52-week change-4.70P/E (Trailing)‪-2.78%‬Profit Margin
- 1LNTHMTALantheus Holdings, Inc.3.88BMarket Cap+46.67%52-week change24.44P/E (Trailing)‪17.69%‬Profit Margin
Profile Summary - 1SOBI - Swedish Orphan Biovitrum AB
About
Swedish Orphan Biovitrum AB is an international biopharmaceutical company headquartered in Stockholm, Sweden, specializing in treatments for rare diseases within haematology, immunology, and specialty care. It focuses on researching, developing, manufacturing, and commercializing innovative therapies for conditions…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
